Company Filing History:
Years Active: 2022
Title: Constanze Obermiller: Innovator in Pharmaceutical Compositions
Introduction
Constanze Obermiller is a notable inventor based in Heidelberg, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of solid pharmaceutical compositions for treating Hepatitis C Virus (HCV). Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical treatments.
Latest Patents
Obermiller holds a patent for "Solid pharmaceutical compositions for treating HCV." This invention features solid pharmaceutical compositions that comprise Compound 1 and Compound 2. In one embodiment, the solid pharmaceutical composition includes a first layer comprising 100 mg of Compound 1, along with a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all formulated in amorphous solid dispersion. Additionally, the second layer consists of 40 mg of Compound 2, also combined with a hydrophilic polymer and surfactant, formulated in amorphous solid dispersion. This innovative approach aims to enhance the efficacy of treatments for HCV.
Career Highlights
Constanze Obermiller is currently associated with AbbVie Inc., a leading global biopharmaceutical company. Her work at AbbVie has allowed her to collaborate with other talented professionals in the field. She has made strides in pharmaceutical research and development, contributing to the advancement of effective treatments for various diseases.
Collaborations
Obermiller has worked alongside esteemed colleagues, including Nancy E Sever and Ulrich Westedt. These collaborations have fostered a productive environment for innovation and have played a crucial role in the success of her projects.
Conclusion
Constanze Obermiller's contributions to pharmaceutical innovations, particularly in the treatment of HCV, highlight her role as a leading inventor in the field. Her patent and collaborative efforts reflect her commitment to improving healthcare outcomes through innovative solutions.